Study of p53 expression in premalignant squamous epithelial lesions of cervix
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20173129Keywords:
Cervical intraepithelial neoplasia, Immunohistochemistry, p53Abstract
Background: Every year in India, 1,22,844 women are diagnosed with cervical cancer and 67,477 die from the disease. This study was done with the aim of studying the expression of p53 in pre-malignant squamous epithelial lesions of cervix.
Methods: Patients coming to our institution who are undergoing biopsy for abnormal cytology/colposcopy were included in the study. Total of 39 patients were studied. Immunohistochemistry was used to study the p53 expression in cervical intra-epithelial lesions.
Results: Out of 39 patients studied, p53 positivity was found in CIN 1 in38.5% cases, CIN 2 and CIN 3 in 80.75%.
Conclusions: The present study has showed that p53 expression increased with increasing severity of Cervical intraepithelial neoplasia (CIN) and this fact can be used in clinical practice to identify those patients who require more surveillance.
References
ICO Information Centre on HPV and cancer (Summary Report 2014-08-22). Human Papillomavirus and Related Diseases in India. 2014
Muñoz N1, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518-27.
Wan F, Miao X, Quraishi I, Kennedy V, Creek KE, Pirisi L. Gene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer. Int J Cancer. 2008;123(1):32-40.
Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990;248(4951):76-9.
Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990;63(6):1129-36.
Lool ML, Dali AZ, Ali SA, Ngah WZ, Yusof YA.. Expression of p53, bcl2 and Ki-67 in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix. Anal Quant Cytol Histol. 2008;30(2):63-70.
Kerkar RA, Kulkarni YV. Screening for cervical cancer: An overview. J Obstet Gynecol India. 2006;56:115-22.
Baalbergen A, Ewing‐Graham PC, Eijkemans MJ, Helmerhorst TJ. Prognosis of adenocarcinoma of the uterine cervix: p53 expression correlates with higher incidence of mortality. Int J Cancer. 2007;121:106-110.
Khattak ST, Khattak I, Naheed T, Akhtar S, Jamal T. Detection of abnormal cervical cytology by pap smears. Gomal J Med Sci. 2006;4:74-7.
Sherwani RK, Khan T, Akhtar K, Zeba A, Siddiqui FA, Rahman K et al. Conventional Pap smear and liquid based cytology for cervical cancer screening: a comparative study. J Cytol. 2007;24:167-72.
National Office for Cancer Prevention and Control. Chinese Cancer Annual Report 2004. Beijing: Publication House of Peking Union Medical College; 2008.
Parimala A, Sharma N, Srinivasan JK. Screening of cancer cervix: Pap smear in rural India. Int J Reprod Contracept Obstet Gynecol. 2017;5(7):2113-5.
Tao L, Han L, Li X, Gao Q, Pan L, Wu L, Luo Y, Wang W, Zheng Z, Guo X. Prevalence and risk factors for cervical neoplasia: a cervical cancer screening program in Beijing. BMC Public Health. 2014;14(1):1185.
Nivedhitha VS, Sankareswari R. Study of effectiveness of combined test Pap smear, visual inspection with acetic acid and Lugols iodine for mass screening of premalignant and malignant lesions of cervix. Int J Reprod Contracept Obstet Gynecol. 2017;5(3):725-9.
Patil S, Patil A, Solanke P. Cytological Screening for early Diagnosis of Cervical Intraepithelial Neoplasia (CIN) and early Carcinoma of Cervix. Int J Sci Res Publ. 2015;5:1-6.
Shukla S, Dass J, Pujani M. p53 and bcl2 expression in malignant and premalignant lesions of uterine cervix and their correlation with human papilloma virus 16 and 18. South Asian J Cancer. 2014;3(1):48.
